Changing utilization of pro re nata ('as needed') sedation in a child and adolescent psychiatric inpatient unit

Australian and New Zealand Journal of Psychiatry

Volumn 43, Issue 4, 2009, Pages 360-365

  Dean, Angela J ^a,b   McDermott, Brett B M ^a,b   Scott, James ^a,b,c  

^a Kids in Mind Research   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Drug utilization; Hypnotics and sedatives; Mental health services; Psychiatric hospitals; Psychotropic drugs

Indexed keywords

ALIMEMAZINE; CHLORPROMAZINE; DIAZEPAM; DROPERIDOL; HALOPERIDOL; MIDAZOLAM; OLANZAPINE; OXAZEPAM; PERICIAZINE; QUETIAPINE; RISPERIDONE; TEMAZEPAM; HYPNOTIC SEDATIVE AGENT;

ADOLESCENT; ADULT; AGGRESSION; AGITATION; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILD CARE; CHILD PSYCHIATRY; DRUG DOSE REGIMEN; DRUG UTILIZATION; FEMALE; HOSPITAL PATIENT; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; MENTAL HOSPITAL; PATIENT CARE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SEDATION; TREATMENT INDICATION; TREATMENT OUTCOME; DRUG ADMINISTRATION; DRUG THERAPY; HOSPITALIZATION; MENTAL DISEASE; METHODOLOGY; PROSPECTIVE STUDY; PSYCHIATRIC DEPARTMENT; PSYCHIATRY; STATISTICS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY; FEMALE; HOSPITALIZATION; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MENTAL DISORDERS; PROSPECTIVE STUDIES; PSYCHIATRIC DEPARTMENT, HOSPITAL; PSYCHIATRY; YOUNG ADULT;

EID: 67650189483     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670902721095     Document Type: Article

References (28)

1. Thomas CP, Conrad P, Casler R, Goodman E. Trends in the use of psychotropic medications among adolescents, to 2001. Psychiatr Servi 57 1994; 2006:63-69.
2. Zito JM, Safer DJ, DosReis S et al. Psychotropic practice patterns for youth: A 10-year perspective. Arch Pediatr Adolesc Med 2003; 157:17-25.
3. Medco Health Solutions. Medco study reveals pediatric spending spike on drugs to treat behavioral problems. Medco Health Solutions, 2004. [cited 23 September 2008.] Available from URL: http://medco.mediaroom.com/ index.php?s=43&item=158
4. Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA. New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med 2004; 158:753-759.
5. Olfson M, Marcus SC, Weissman MM, Jensen PS. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 2002; 41:514-521.
6. Zito JM, Safer DJ, DosReis S et al. Rising prevalence of antidepressants among US youths. Pediatrics 2002; 109:721-727.
7. Lekhwani M, Nair C, Nikhinson I, Ambrosini PJ. Psychotropic prescription practices in child psychiatric inpatients 9 years old and younger. J Child Adolesc Psychopharmacol 2004; 14:95-103.
8. Vitiello B, Ricciuti AJ, Behar D. P.R.N. medications in child state hospital inpatients. J Clin Psychiatry 1987; 48:351-354
9. Stein-Parbury J, Reid K, Smith N, Mouhanna D, Lamont F. Use of pro re nata medications in acute inpatient care. Aust N Z J Psychiatry 2008; 42:283-292.
10. Kaplan SL, Busner J. The use of prn and stat medication in three child psychiatric inpatient settings. Psychopharmacol Bull 1997; 33:161-164.
11. Dean AJ, McDermott BM, Marshall RT. PRN sedation: Patterns of prescribing and administration in a child and adolescent mental health inpatient service. Eur Child Adolesc Psychiatry 2006; 15:277-281.
12. Curtis J, Capp K. Administration of 'as needed' psychotropic medication: a retrospective study. Int J Ment Health Nurs 2003; 12:229-234.
13. Usher K, Luck L. Psychotropic PRN: A model for best practice management of acute psychotic behavioural disturbance in inpatient psychiatric settings. Int J Ment Health Nurs 2004; 13:18-21.
14. Thapa PB, Palmer SL, Owen RR, Huntley AL, Clardy JA, Miller LH. P.R.N. (as-needed) orders and exposure of psychiatric inpatients to unnecessary psychotropic medications. Psychiatr Serv 2003; 54:1282-1286.
15. Dean AJ, Duke SG, George M, Scott J. Behavioral management leads to reduction in aggression in a child and adolescent psychiatric inpatient unit. J Am Acad Child Adolesc Psychiatry 2007; 46:711-720
16. Thomas B, Jones M, Johns P, Trauer T. P.r.n. medication use in a psychiatric high-dependency unit following the introduction of a nurse-led activity programme. Int J Ment Health Nurs 2006; 15:266-271.
17. O'Connell DL, Henry D, Tomlins R. Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia. BMJ 1999; 318:507-511.
18. Mugford M, Banfield P, O'Hanlon M. Effects of feedback of information on clinical practice: A review. BMJ 1991; 303:398-402.
19. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care 2006; 15:433-436.
20. Forster PL, Buckley R, Phelps MA. Phenomenology and treatment of psychotic disorders in the psychiatric emergency service. Psychiatr Clin North Am 1999; 22:735-754.
21. Dean AJ, McDermott BM, Marshall RT. Psychotropic medication utilization in a child and adolescent mental health service. J Child Adolesc Psychopharmacol 2006; 16:273-285.
22. Wheeler A, Kairuz T, Sheridan J, McPhee E. Sedativehypnotic treatment in an acute psychiatric setting: Comparison with best practice guidance. Pharm World Sci 2007; 29:603-610.
23. Petti TA, Stigler KA, Gardner-Haycox J, Dumlao S. Perceptions of P.R.N. psychotropic medications by hospitalized child and adolescent recipients. J Am Acad Child Adolesc Psychiatry 2003; 42:434-441.
24. Masters KJ, Bellonci C, BernetWet al. Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint. J Am Acad Child Adolesc Psychiatry 2002; 41:4S-25S.
25. Davies SJ, Lennard MS, Ghahramani P, Pratt P, Robertson A, Potokar J. PRN prescribing in psychiatric inpatients: Potential for pharmacokinetic drug interactions. J Psychopharmacol 2007; 21:153-160.
26. Barzman DH, DelBello MP, Forrester JJ, Keck PE Jr, Strakowski SM. A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: Prospective studies are needed. J Child Adolesc Psychopharmacol 2007; 17:503-509
27. Curtis J, Baker JA, Reid AR. Exploration of therapeutic interventions that accompany the administration of p.r.n. ('as required') psychotropic medication within acute mental health settings: A retrospective study. Int J Ment Health Nurs 2007; 16:318-326.
28. Russell PS, George C, Mammen P. Predictive factors for polypharmacy among child and adolescent psychiatry inpatients. Clin Pract Epidemol Ment Health 2006; 2:25.